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Metagenomic Detection Methods in Biopreparedness
Outbreak Scenarios
Oskar Erik Karlsson, Trine Hansen, Rickard Knutsson, Charlotta Lo¨fstro¨m, Fredrik Granberg,
and Mikael Berg
In the field of diagnostic microbiology, rapid molecular methods are critically important for detecting pathogens. With
rapid and accurate detection, preventive measures can be put in place early, thereby preventing loss of life and further
spread of a disease. From a preparedness perspective, early detection and response are important in order to minimize the
consequences. During the past 2 decades, advances in next-generation sequencing (NGS) technology have changed the
playing field of molecular methods. Today, it is within reach to completely sequence the total microbiological content of
a clinical sample, creating a metagenome, in a single week of laboratory work. As new technologies emerge, their
dissemination and capacity building must be facilitated, and criteria for use, as well as guidelines on how to report results,
must be established. This article focuses on the use of metagenomics, from sample collection to data analysis and to some
extent NGS, for the detection of pathogens, the integration of the technique in outbreak response systems, and the risk-
based evaluation of sample processing in routine diagnostics labs. The article covers recent advances in the field, current
debate, gaps in research, and future directions. Examples of metagenomic detection, as well as possible applications of the
methods, are described in various biopreparedness outbreak scenarios.
The concept of preparedness as applied to biologicalthreats is not new. The Science for Peace and Security
program adopted ideas related to this theme in 1956.1
Biological threats directed toward animals have also been
described in historical records and, more recently, the use of
anthrax was reported as having been used as a weapon
during World War I.1A In the field of animal health, the
World Animal Health Organization (OIE) produces and
distributes manuals, guidelines, and recommendations as
well as standardized methods for veterinary science. In
addition, the World Health Organization (WHO) has
published recommendations on how to prepare for terrorist
threats to food.2 Given the nature of pathogens and the
widespread consequences of their release, there is a need for
a structured international framework and a coherent view
in battling outbreaks.
In biopreparedness there are several subsections, all
equally important, and they can be divided in 2 groups:
capacity building and capacity evaluation.3 Capacity is built
according to intelligence and risk assessment; training is
then required to evaluate effectiveness and provide further
input for capacity building. Capacity build-up and research
fulfill important roles as sources of intelligence, tools to
battle threats, and a methodology for implementation,
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evaluation, and risk assessment. The AniBioThreat Euro-
pean Union project aims at increasing the European Un-
ion’s (EU) capacity to counter animal biological threats by
building biopreparedness.4
Animal Biological Threats
Animal biological threats can be of 2 types: threats directed
toward animals and threats aimed at the human population
by distribution through animals.5 With direct threats, the
production chain is targeted, and such attacks can lead to
economic loss as well as having a socioeconomic impact and
an effect on morale, in addition to the logistical challenges of
handling the outbreak itself. In the second type, animals are a
means to an end, the human target. The OIE estimates that
up to 80% of the pathogenic agents suggested for use in
bioterrorism have zoonotic origins and as such can be har-
bored by both animal and human hosts.6 Given the often
close proximity of farm production plants to populated areas,
as well as the high density of animals in production facilities,
large-scale outbreaks, whether artificial or natural, can have
serious economic and health consequences if not controled.
Detection Methods
Rapid detection and proper risk assessment are crucial tools
in countering biological threats. It is important to quickly
detect and confirm the specific infection for effective out-
break control. Studies from Canada estimated that a 1-week
delay in implementing control measures for a severe acute
respiratory syndrome resulted in a 2.6-fold increase in the
mean epidemic size and an extension of 4 weeks of the
mean epidemic duration.7 The traditional culture-based
methods, as well as the immunologic and nucleic acid–
based methods, suffer from a number of drawbacks when
dealing with novel or unknown organisms. There are no
validated culture-based methods for all organisms, and
sometimes methods have poor specificity. Immunological
and nucleic acid–based methods have a high specificity,
making them unable to (or to very little extent) detect or-
ganisms outside of their target range. In contrast, metage-
nomics, a method in which the combined genomes of all
organisms present in a sample are analyzed, represents a
broad range, high-throughput methodology for detection
that requires little or no prior knowledge of the target. This
can be of crucial importance when encountering a novel or
unexpected target, as it removes the initial lag caused by
identification issues.
Metagenomics
Metagenomics, the genetics subfield studying the combined
genomes of a sample and their interaction, is a quickly
growing field. Not only does it offer a rapid high-
throughput method for mapping interactions in a micro-
bial community, but it also circumvents the need for
culturing, which enables the study of the unculturable
majority of microorganisms in a microbial community.8
Next-generation sequencing (NGS) has been suggested as a
future application that can improve the response to a bio-
terrorism incident in the food chain.9 Metagenomics can,
for instance, be useful in enabling earlier discovery of novel
emerging viruses and bioterrorism incidents.10-12 However,
using metagenomics approaches in bioterrorism response
requires interoperability between biodefense databases.13
Metagenomics also represents a new logistics problem for
laboratories implementing the technology: data storage.
The falling price of sequencing not only allows for large-
scale sequencing investigations but also enables production
of enormous amounts of data. Given that the price of
storage is steadily increasing and that the computational
overhead for analysis is rising with dataset complexity, this
is one of the largest obstacles when implementing large-
scale metagenomics for screening and diagnostics.14
Target-Specific Approach
The traditional approach for DNA sequencing was intro-
duced in the 1970s by Sanger, and this method is capable of
retrieving up to 1 kb of sequence data at a time.15 Even
though Sanger sequencing has been used for several meta-
genomics projects, the high demand for low-cost sequenc-
ing has caused a shift to use of NGS platforms.16,17 Because
of the high genetic diversity of most microbial communi-
ties, it is currently difficult to obtain enough sequence
depth to sample any gene with sufficient coverage to get
meaningful information on the diversity or population
characteristics. To overcome this difficulty, target-specific
metagenomics, which aims to obtain sequence reads from
specific genes of interest based on prior knowledge of se-
quence information, can be a useful tool.18
The first step in a metagenomic investigation is the
amplification of single targets using polymerase chain re-
action (PCR); the products are then sequenced either by
Sanger sequencing or NGS methods.19,20 Target-specific
metagenomics generates low amounts of data compared
with whole-genome sequencing (WGS), thus allowing
analysis of pathogen diversity in communities in a shorter
time. This method is therefore useful for screening of
pathogens in samples before WGS.
Whole-Genome Approach
The whole-genome approach was pioneered to detect
viruses using broad range PCR methods in the late 1990s
and early 2000s.21,22 With the introduction of affordable
sequencing, and in the wake of the technological develop-
ments during the Human Genome Project, massive
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paralleled Sanger sequencing became a reality and with it
the ability to sequence large amounts of clonal libraries at
once.23 Following the first few pioneering experiments,
several important discoveries were made within 5 years,
proving that our understanding of viral diversity in host
species (in this case, human) was so far largely unex-
plored.24-27 Given the introduction of NGS platforms in
2005, the field quickly expanded to encompass this new
technological breakthrough. Several successful studies and
proof of concept articles were produced in a relatively short
span, and in 2012, a total of 198 articles using deep se-
quencing for detection of viruses were published. Whole-
genome based approaches also were used for the
bioterrorism investigation of the anthrax letters in the
Amerithrax case.28
The whole-genome methodology involves the isolation
of genetic material from the sample, enrichment toward the
target, enrichment using nonspecific amplification strate-
gies, and finally deep sequencing of the sample. Strategies
for sample preparation (extraction of genomic material and
enrichment of target-specific material) and amplification of
material vary greatly between groups.29 Some favor the
unmodified version that was first pioneered (with both
enrichment toward target organism as well as amplifica-
tion), while others suggests that this might introduce undue
bias into the datasets.30 Both methodological approaches
have merit and are proven principles described in several
articles in the literature.
Technical Review of Metagenomics
Two things are of outmost importance for metagenomic
applications: to preserve the metagenome as intact as pos-
sible, and to provide as much contextual information as
possible. For possible forensic or epidemiologic use, the
contextual metadata provided with the sample might be
just as important as the sample itself.
Sampling
Metagenomics presents a unique challenge to first re-
sponders and field personnel performing the sampling
when it comes to deciding what to sample. Because meta-
genomics has a proven efficiency for detection in solids,
liquids, and environmental samples, the need for awareness
of one’s surroundings for correct sampling is essential.
There are many different sample types to be considered,
including clinical, water, vegetables, feed, and environ-
mental samples. These sample types have various metadata
that should be evaluated for complete analysis of the results.
For clinical samples, the OIE terrestrial manual is the
gold standard for methodologies considering animal health
and animal welfare, including disease control and surveil-
lance sampling.31,32 The main samples to be taken from a
live animal are blood, feces, skin, genital tract swabs and
semen, eye and nasal discharge, and milk. For postmortem
investigations, the normal guidelines for necropsy should
be applicable.33 When sending samples, a risk assessment
according to OIE guidelines, as well as the guidelines for
the select agents list, should be made concerning possible
risks associated with entry, exposure, and the consequences
thereof.34
Sample Treatment
Depending on the sample type, different pretreatments can
be used. Each sample type requires a specific protocol, and
various types of methods for extraction of nucleic acids are
available.35-37 If extraction of nucleic acids of microor-
ganisms is associated with a host (eg, plants or animal
parts), selective lysis are required to ensure minimal con-
tamination of nucleic acids from the host in the subsequent
analysis.38
For liquid samples, selective filtration is an opportunity,
whereas for solid samples separation and isolation of cells is
an alternative strategy.16,39,40 Liquid samples can be rep-
resented by both water and various fluids from animals.
The ability of the metagenomics approach to detect not
only known but also unexpected and unknown microor-
ganisms has been extensively evaluated and proven to work
for liquid samples.24,41-43 The general procedure is to
concentrate the sample and then take a fraction of the
sample for sequencing. Solid material can be from envi-
ronmental samples (eg, swabs from surfaces), food, feed, or
whole organs or partial animal parts. Extraction from soil
and sediments (eg, environmental samples) is often more
difficult than pure cultures because of the presence of in-
hibitors. The inhibitor can originate from soil compounds
that might inhibit the extraction or compounds that co-
purifiy with the nucleic acids, such as humic acids, which
can interfere with downstream applications.44-46 For these
types of samples more thorough sample treatments are
needed.47 The sample preparation has been shown to in-
fluence results from metagenomics analysis—for example,
when introducing a freezing step to store the samples before
analysis48 and when starting with a culture enrichment
step.49
Since 9/11 and the Amerithrax case, microbial forensics
has been developing at great speed. When a forensic in-
vestigation of an outbreak is performed, it would be pru-
dent to perform the examination in the way that human
medical forensics are conducted, if results are to be included
in a possible forensic investigation at a later point. The
literature lists several procedures to be taken for preserving
and stabilizing samples used for forensic microbiology.50
Three main areas can be of interest: extraction techniques
and applications, preserving and stabilizing samples, and
assessing and controling sample contamination. All of these
are extensively covered in other literature and will not be
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discussed here in more detail.32 Figure 1 provides a sche-
matic view of sampling and sample preparation procedures.
Sequencing Technologies
For a considerable amount of time, the long read length
paradigm held true for metagenomic studies; thus, tech-
nology was chosen based on how long a read it could
produce. This resulted in a number of high-profile novel
virus articles, as well as microbial 16S rDNA sequencing to
characterize microbial communities. As read length was the
main criterion for choosing technology, the Massively
Parallel Pyrosequencing, 454 Roche, was the primary
choice in metagenomic studies incorporating NGS.39,51-53
The introduction of the Four-Color Reversible
Chain Termination (Illumina, HiSeq) technology allowed
Figure 1. Samples are collected in the field. Following classification and collection of possible metasamples (samples related to the
incident site such as feed or water for the animals), risk assessment is performed on site, and samples are packaged in accordance with
OIE recommendations and international rules for transport of biological specimens. As samples arrive at the diagnostic lab, they are
homogenized, cell debris is removed, and, depending on agents of interest, an optional DNase/RNase step is performed to degrade
parts of the metagenome. Nucleic acid extraction is performed on the samples, and they are stored. Samples can now pass through 2
optional steps: whole genome amplification or targeted amplification (eg, 16S rDNA amplification). Sequencing is performed, and raw
sequencing data are produced.
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unbiased broad-range sequencing of the microbial com-
munity. In this approach, relatively short reads are sorted
and classed into subgroups and thereafter analyzed. Even
though this method has proven useful, the shear amount of
sequence reads, as well as time-consuming analysis and lack
of specificity, are factors limiting an extensive use of this
technique.54-57
In 2011 LifeTechnology released the Personal Genome
Machine (PGM). The PGM employs a technique called
sequential electrical detection, in which sequencing of the
template strand is performed inside a microchip, directly
transferring the released ions into the semiconductor,
thereby reading the sequence by the current produced.58,59
Choosing Sequencing Technologies
The choice of sequencing technology for metagenomic
investigations is based on 4 main factors: length of se-
quences, depth of sequencing/throughput of technology,
speed of sequencing, and automation availability.60-62
Length of sequences still plays a major role in allowing easy
alignment toward genomes of interest, spanning possible
repetitive regions, and providing sequence islands in
the target genome for further sequencing.63 Depth and
throughput of sequencing depends on (1) how selective you
have to be with your sample (selection of parts of the mi-
crobiome or presequencing sample preparation), and (2)
how many samples you can multiplex (design of assay). The
speed of sequencing is of utmost importance from a bio-
preparedness perspective; technologies taking up to 2 weeks
to finish a run are of limited use in an outbreak situation.
Finally, automation and the possibility of making the
metagenomic approach interoperable in the current auto-
mated diagnostic pipeline are factors to consider.
Table 1 presents a compilation of data as given by the
sequencer manufacturers adjusted for experimental results,
including possible applications, costs for running and ac-
quiring the instrument, and speed for a single run. In 2012,
Loman et al provided an excellent initial overview of the
newly introduced benchtop sequencers.60 The IonProton
was introduced after the experiment, as were the increased
read-length chemistry for MiSeq and IonTorrent. Sug-
gesting a single technique is therefore complicated. At the
time of the writing of this article, MiSeq held the lead in
throughput for the 250bp chemistry and has a compelling
sample preparation, whereas the IonTorrent provides lon-
ger read lengths and faster sequencing turnover. The cap-
abilities of the benchtop sequencers do, however, regardless
Table 1. List of Sequencing Technologies, Their Properties, and Possible Applications
Technology Applications
Minimum
Throughput (Read Length) Run Time Cost (Run Price)
454 (Roche) Small genome, targeted sequencing,
transcriptome, metagenomics
700 Mb (up to 1kb) 23 hours *$500k (*$6k)
454 Junior Small genome, targeted sequencing 35 Mb (*400b) 10 hours $125k (*$1k)
Illumina HiSeq Eukaryote whole genome, exome, targeted
sequencing, small genome, transcriptome,
metagenomics
600/120 Gb
(2· 100/150)
11 days/
27 hours
$690k/$740k
(*$23k)
Illumina MiSeq Exome, small genome, targeted
sequencing
*4 Gb (2 · 150) 24 hours $125k ($965)
SOLiD Whole eukaryote genome, exome,
transcriptome, metagenomics, small genome,
targeted sequencing
95 Gb (2 · 60) 6 days $595k (*$10k)
SOLID Wildfire Whole eukaryote genome, exome,
transcriptome, metagenomics, small genome,
targeted sequencing
240 Gb (2 · 50) 10 days $70k upgrade
(*$5k)
Ion Torrent 314 Small genome, targeted sequencing,
metagenomics
10-40Mb
(200b)
2-3 hours $50k ($350)
Ion Torrent 316 Small genome, targeted sequencing,
metagenomics
100-400Mb
(200b)
2-3 hours $50k ($550)
Ion Torrent 318 Small genome, targeted sequencing,
metagenomics
*1Gb (200b) 2-3 hours $50k ($750)
Ion Proton I Eukaryote whole genome, exome, targeted
sequencing, small genome, transcriptome,
metagenomics
*10Gb (100b) 2-4 hours $149k ($10k)
Ion Proton II Eukaryote whole genome, exome, targeted
sequencing, small genome, transcriptome,
metagenomics
*30Gb (100b) 2-4 hours $149k (*$10k)
Note. The list includes the benchtop version if possible (454 Junior, Illumina MiSeq, and Ion Torrent/Proton Torrent), speed of sequencing as well as
possible mean read length, and total data output together with procurement costs and running costs.
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of platform, provide medium-sized laboratories with a good
capability to provide rapid metagenomic analysis of clinical
samples on a medium scale. The technology will also likely
be developed considerably in the near future, making it
simpler and having even more capacity.
Bioinformatics and Processing
of Data
An integral part of NGS technologies is the postsequence
processing of data. After the data have been produced by the
chosen sequencing technology, the output is often an abun-
dance of sequence reads with little or no meaning to the
untrained eye. Postsequencing processing is applied to raw
sequence data to perform quality control (QC), filter reads for
contamination, map reads toward relevant genomes, assem-
ble genomes (or partial genomes), and perform homology
searches and taxonomic/phylogenetic studies.29,64,65 This is
shown in Figure 2 as a flowchart of methodologies and im-
plementation of methodologies for analysis.
Quality of datasets for metagenomic analysis consists of
several parts. First, base calling is generally performed by the
vendor implementation, crafted into the technology itself,
filtering away reads of dubious quality and providing the user
with an output from the sequencer.66 After the initial filtering,
the resulting dataset is usually composed in a data format
containing all the relevant information in 1 file. Most vendor
pipelines also include the possibility for directly mapping the
data toward a genome, giving the user the possibility to map
sequences toward several microbial organisms or to map se-
quences toward the host genome for removal. Mapping of
reads toward a genome is functional when a known genome is
present; this can either be a host genome (to more efficiently
filter the reads and get an estimate of host contamination) or
added process controls.67,68 This step is normally not used
extensively for metagenomic analysis since the strength lies not
Figure 2. Raw data from sequencing is checked for quality irregularities. Tags from sequencing technology and/or preamplification
step are removed, and reads are optionally filtered toward host genome or known contaminating genome (eg, process controls, etc).
The preprocessed dataset is split into 2 paths, 1 performing assembly of the reads and 1 mapping the reads directly. Products from
assembly are then subjected to the same sort of homology search as the single reads. Finally, the datasets are combined and evaluated
for taxonomic classification.
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on what you know is in the sample but in the broad range of
detection. Users can then apply several different quality checks
on the dataset to determine its validity for the experiment.
During processing the identification and removal of
systematic artifacts is also of great importance, as bias in-
troduced this way can skew the analysis and provide a
shifted final picture of the metagenome.69 By combining
several tools, the user can remove most artificial duplicate
reads, clean away tag sequences, assess guanine-cytosine
content, trim the sequences, and provide initial filtering by
quality, ambiguous base, and sequence complexity.70 After
initial filtering, as much as 80% to 95% of the initial read
counts can be removed, depending on the presequencing
processing.55,71 This provides the user with a considerably
easier dataset to handle. Combined with classification of
sequence reads, assembly of short reads can render addi-
tional information about the organisms present in the
metagenome. Because of the complex nature of metage-
nomic datasets, assembly can introduce various in silico
artifacts into the dataset.72 These artifacts can be of a dif-
ferent nature, but usually include chimerical contigs and
ultradeep contigs. Assemblers are continuously developing
new applications, and several metagenomic assemblers have
been introduced in the past few years.73,74 These assemblers
aim at taking the complexity of the metagenome into the
assembly, thereby offsetting the possible assembly bias.
Moreover, these provide individual unique sequences into
the final dataset, thus preserving data for the final analysis.
The final step of a metagenomic analysis is the classifi-
cation of the sequences. Classification is usually performed
by homology-based methods, but both composition-based
methods and phylogenetic methodologies exist. These 3
main approaches are sometimes also combined for in-
creased speed and accuracy. (See the review by Bazinet and
Cummings for extensive information about classifica-
tion.75) It is noteworthy that homology-based methods
have high accuracy and can be fast when using a small
database for the query. This provides a possible use for
rapidly mapping of a metagenomic sample toward, for
example, the select agent, giving fast information about the
agents present in a sample.76
When reporting metagenomic results, it is important to
take into consideration the metadata. The Genomic Stan-
dards Consortium provides guidelines for reporting meta-
genomes. Combined with proper sample documentation
according to the OIE sampling standards, these guidelines
will suffice for most in-depth analyses of metagenomes for
several applications, including preparedness questions or
basic science.77
Metagenomics-Based Approaches
in Outbreak Investigations
There are several examples of how metagenomics-based
approaches have been used in investigations aimed at
finding the source and origin of a disease outbreak, in-
cluding bacteria, viruses, and parasites.42,78-81 We present 2
examples to explain the usefulness of applying metage-
nomics in an outbreak situation when other diagnostic
tools were found to be insufficient.
Regions in North Rhine-Westphalia, Germany, and in
the Netherlands started in 2011 to see a decline in milk
production, and several clinical signs such as fever and di-
arrhea in cows were identified. Conventional methods
failed to establish the source of the infection, and rea-
sons for the decreased milk production were unclear. The
Friedrich-Loeffler Institute, Germany, therefore launched a
metagenomic study using the 454 Genome Sequencer FLX
technology. During sequence analysis, a homology toward
7 orthobunyavirus sequences was discovered. Using re-
peated sequencing of the original library rendering the
reads, a partial viral genome was recovered. Filling the gaps
with conventional Sanger sequencing, the Schmallenberg
virus was described on a genome level.43,82
Another case was the enterohemorrhagic Escherichia coli
(EHEC) outbreak in Germany in 2011. This case dem-
onstrated how sequencing technologies could be used in the
early stages of an outbreak to characterize the causative
agent of the outbreak.83 The outbreak strain was shown to
be a hybrid, which means that the current molecular
methods used for detection, relying on either detection of
virulence genes that are linked to known bacterial serotypes
or detection of only the virulence genes, were found to be
unable to detect and correctly characterize the outbreak
strain. The use of WGS enabled identification of sequences
that were specific to the outbreak strain.78
Discussion
The evolution of high-throughput sequencing (HTS)
technologies toward inexpensive equipment and sequenc-
ing runs is slowly making an impact in clinical laboratories.
As with all technology introductions, laboratories are now
faced with the enormous task of standardizing methodol-
ogies and procedures and incorporating results from the
new technology into the communication and command
structure. In outbreak situations with unknown agents, the
criteria for detection are, however, somewhat less stringent
than in routine diagnostics. Therefore, NGS-based tech-
nologies and methodologies can be a powerful tool in
preparedness for detecting unexpected microorganisms.84
Diagnostic Use of Metagenomics
The major obstacles to diagnostic use of metagenomics are
the timeframe of the analysis and the lack of experienced
personnel to perform the data analysis. The first point is
slowly resolving itself as the benchtop sequencers today are
moving into a 2-day preparation and sequence timeframe.
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This is comparable to culture-based and serological meth-
ods. The second point is more critical, as the lack of trained
informatics personnel is at the moment a serious problem.
There is to our knowledge no available and thoroughly
tested standard NGS methodology for use in an outbreak.
Consequently, there is a need to develop standard operating
procedures (SOPs) for field-based sampling by veterinarians
or first responders, as well as to develop sample preparation
protocols in clinical laboratories. Core facilities, for exam-
ple, in the EU, should engage in interoperability exercises to
ensure common understanding of the methodologies, to
exchange expertise, and to identify research needs.
In an outbreak situation, where the origin of the causative
agent is not known, the extraction of nucleic acids in a
representative manner is the major hurdle for success. Ex-
traction of nucleic acids directly from the sample might
introduce bias of the purified DNA or RNA, which in the
end could produce misleading results. The methods used for
lysis of the cells affect the composition of the total nucleic
acid present, since harsh lysis methods that are needed for
extraction of DNA from some bacteria (eg, Gram-positive
bacteria) might degrade DNA or RNA from others.85
Current research has been focused on the detection of
novel viruses, a process performed differently depending
on, for example, group, sample accessibility, experimental
planning, and technology used for NGS. In virology, me-
tagenomics is a proven methodology for detecting unex-
pected or novel viruses in clinical samples.84 When it comes
to the bacterial field, metagenomics has mainly been used
for investigation of large bacterial communities, such as the
human gut, or for environmental samples.16,86 However,
the use for diagnostic purposes is emerging.
Additionally, the discussion about sequence-based mi-
crobiology must be taken further. The same caveat as with
PCR-based technologies exists; finding DNA or RNA of an
organism does not prove the presence of a living or intact
form of that organism. Several factors can produce false-
positive results, and with the need for some assembly in
several NGS technologies the risk for technological artifacts
increases. For well over 100 years, Koch’s postulates have
been seen as a gold standard for detection of pathological
entities. Late in the last century, these postulates came under
question with the broad introduction of nucleic acid–based
methods into diagnostic microbiology. With the subsequent
introduction of NGS methods, there is a clear need for
microbiologists to redefine the criteria for how to define
causative agents, as reviewed extensively by others.84,87
Theoretical Applications
in Diagnostic Preparedness
Metagenomics is today one of the few molecular methods
for detection of novel microorganisms, as well as a tool with
extreme throughput capabilities. It is our belief that in
metagenomics there is a methodology for the unbiased
detection of the microflora of a sample, thus offering a
diagnostic capability for tracing introduced organisms at an
unprecedented level. In other words, metagenomics can
detect several pathogenic organisms in 1 sample, including
genetically modified versions of known pathogens. Several
different disciplines in the preparedness structure could use
such a method applied to microbial forensics, smuggling,
outbreak investigations, and R&D needs.
Microbial Forensics
Microbial forensics aims at detecting microorganisms from
a forensic perspective—that is, detection of microorganisms
provides forensic clues to investigators.88 In a preparedness
structure, the forensic field can be seen as a part of the
epidemiologic work of tracking the origin of introduction.
There is also the direct forensic approach in the possible
deliberate spread of microorganisms where metagenomics
can provide both traceability and detection.
Customs and Smuggling
It is feasible to theorize that high-resolution metage-
nomics will provide profiling indicating the geographic
origin of individual animals. As such, one could hy-
pothesize that it is possible to use metagenomic profiles of
the gut microbiota to determine the origin of animals.
Previously, we discussed the broad range of detection, the
ability to handle a large amount of samples, and the
multiplexing capability. This fits well into the customs
perspective: large amounts of material to be tested, un-
known origin, unknown agents, and possible grave con-
sequences if organisms slip the grid. Given the movement
of illegal animals in the EU and globally, large-scale se-
quencing for broad screening might be implemented in
the near future. This would also include the legal and
illegal trade of food commodities.
Determining the Causative Agent of an Outbreak
In microbiology, and virology in particular, metagenomics
is an important technique to strengthen the capability to
handle previously uncharacterized microbial agents and to
provide diagnostic laboratories with previously unattain-
able capabilities for handling outbreaks.
Research Needs
In general, the time from sample to proof of presence of a
potential pathogen needs to be speeded up considerably. All
steps in the analytical chain (Figure 2) can be improved and
simplified, as well as automated. At the moment focus
should be put on the bioinformatics, to develop easy-to-use
programs that ideally can warn of the presence of potential
pathogenic microorganisms in a given sample. A follow-up
on this would be to, in the same set, suggest primers for fast
real-time PCR detection of the detected organisms, coupled
to an oligonucleotide synthesizer that synthetizes new
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oligonucleotides that can be used for further strengthening
of the proof of the presence of the given pathogen.
In virology there is a clear need for validation of meth-
odology toward a larger sample set of domestic animals.
Producing a gold standard for metagenomes, artificial or
naturally occurring, would also prove beneficial. As with
most molecular techniques involving virology, isolation of
the complete viral genome from a clinical sample should be
standardized and implemented in diagnostic laboratory
procedures. As discussed, the need for establishing whole-
genome amplification methods, selective toward microor-
ganisms, and incorporating them into the workflow might
be of great use, but the increasingly powerful sequencing
equipment might evolve to provide solutions that make this
need redundant.
Discussion about the cut-off and reporting of results must
also be taken into consideration for implementation in a
preparedness setting. Possibly harmful information such as
the presence of a pathogen on the restricted list or novel
organisms must have standardized procedures for validation.
For large-scale viral screening, the metagenomic ap-
proach can be combined with bioinformatics solutions to
select for only viral genomes, greatly speeding up the pro-
cess of aligning sequence results toward possible agents.
This combined with a backlog procedure for analyzing the
whole metagenome, preferably automated, could greatly
improve the rate of detection of novel and emerging viruses.
Further research is also needed for bacteria. The major
need is for optimized and standardized methods for sampling
and extraction of nucleic acids. Standardized methods should
also include ways to quantify possible bacterial contamina-
tion to investigate if what is seen is out of the ordinary.
Another area that needs more focus is the link between
genotype and phenotype. The uncertainty in predicting the
phenotype solely on genomic or metagenomic data implies
that the culture-based techniques never will be completely
replaced.89 Furthermore, for certain toxin-producing bac-
teria (eg, Clostridium botulinum) it is not necessarily the
bacterium itself that is the causative agent, but the toxins.
The presence of active toxins cannot be identified by ge-
nome-sequencing techniques. For this reason, other tech-
niques are needed such as the Endopep-MS, in which the
presence and activity of toxins is investigated.90
Conclusions
This article has identified potential applications of meta-
genomics technologies for biopreparedness applications.
For instance, metagenomic approaches for molecular de-
tection of microbial agents are important in a bioprepa-
redness perspective and hold great merit for laboratory
response capabilities. Not only does it improve on the
current molecular methods in throughput and flexibility, it
also presents the only currently unbiased high-throughput
methodology for broad screening of samples. Metagenomes
as a research field also provides new insights into bio-
markers produced by the microorganisms connected to
animals, enabling new tracing of food and feed as well as
possible forensic applications.
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